HIV Research: Breakthroughs, Treatments, and What’s Next

When we talk about HIV research, the scientific effort to understand, treat, and ultimately end the human immunodeficiency virus. Also known as AIDS science, it’s the reason millions now live long, healthy lives with a virus that was once a death sentence. This isn’t just about pills — it’s about shifting the entire trajectory of a global health crisis through smarter drugs, better prevention, and deeper biology.

Antiviral therapy, the use of drugs to stop HIV from multiplying in the body is the backbone of modern HIV care. Today’s regimens, like those containing tenofovir or dolutegravir, can reduce viral load to undetectable levels — meaning the virus can’t be passed on. That’s not theory. It’s proven by studies like PARTNER and HPTN 052. And it’s why people on consistent treatment now have near-normal life expectancy. But it’s not just about taking pills. HIV prevention, strategies to stop transmission before it starts has exploded. PrEP (pre-exposure prophylaxis) is now widely available, and long-acting injectables are replacing daily pills for some. Even vaccines are in late-stage trials, with mRNA tech — the same used for COVID shots — showing real promise.

What’s missing from most headlines? The human side. HIV research isn’t just labs and data. It’s about access. It’s about why someone in rural Africa still can’t get a test. It’s about stigma that keeps people from speaking up. And it’s about how older adults, once thought to be low-risk, are now the fastest-growing group of new diagnoses in some countries. The science is advancing, but the system isn’t always keeping up.

Below, you’ll find real, practical guides based on current HIV research — from how new drugs compare to older ones, to how managing other conditions like kidney disease or liver health affects HIV treatment. You’ll see how medications like sofosbuvir — originally for hepatitis C — now play a role in co-infection care. You’ll find clear advice on drug interactions, side effects, and what to ask your doctor. No fluff. No jargon. Just what you need to understand your options, protect your health, and stay informed as the science moves forward.

23

Oct

Efavirenz, Emtricitabine & Tenofovir: How Clinical Trials Shape HIV Treatment

Explore how landmark clinical trials established the efavirenz‑emtricitabine‑tenofovir regimen and why it remains a cornerstone of HIV therapy.

view more